Interleukin-6 role in head and neck squamous cell carcinoma progression.

about

A mathematical model for IL-6-mediated, stem cell driven tumor growth and targeted treatment.Immune Checkpoint Inhibition in Head and Neck Cancer

P2860

Q47557037-C786AA85-4719-4A85-ACE9-F5C7844585BE Q58694216-A156F810-A0F0-4DC6-B5D0-681B9990123C

P2860

Interleukin-6 role in head and neck squamous cell carcinoma progression.

Item

http://www.wikidata.org/entity/Q55031288

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Interleukin-6 role in head and neck squamous cell carcinoma progression.

@en

Interleukin-6 role in head and neck squamous cell carcinoma progression.

@nl

type

Item

label

Interleukin-6 role in head and neck squamous cell carcinoma progression.

@en

Interleukin-6 role in head and neck squamous cell carcinoma progression.

@nl

prefLabel

Interleukin-6 role in head and neck squamous cell carcinoma progression.

@en

Interleukin-6 role in head and neck squamous cell carcinoma progression.

@nl

P1476

Interleukin-6 role in head and neck squamous cell carcinoma progression.

@en

P2093

Moaz M Choudhary

http://www.w3.org/2001/XMLSchema#string

Pawan Kumar

http://www.w3.org/2001/XMLSchema#string

Theodoros N Teknos

http://www.w3.org/2001/XMLSchema#string

Thomas J France

http://www.w3.org/2001/XMLSchema#string

P2860

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells

Molecular cloning and expression of an IL-6 signal transducer, gp130

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway

A high-affinity fully human anti-IL-6 mAb, 1339, for the treatment of multiple myeloma

The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy

Cancer statistics, 2012

Bioavailability of curcumin: problems and promises

Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130

P304

90-97

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1016/J.WJORL.2016.05.002

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29204553

http://www.w3.org/2001/XMLSchema#string

P932

5698512

http://www.w3.org/2001/XMLSchema#string

Interleukin-6 role in head and neck squamous cell carcinoma progression.

about

P2860

P2860

Interleukin-6 role in head and neck squamous cell carcinoma progression.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932